Terlipressin for Children with Severe Septic Shock
Author Information
Author(s): Antonio Rodríguez-Núñez, Jesús López-Herce, Javier Gil-Antón, Arturo Hernández, Corsino Rey
Primary Institution: Hospital Clínico Universitario de Santiago de Compostela
Hypothesis
The study aims to report the effects of terlipressin as a rescue treatment in children with catecholamine refractory hypotensive septic shock.
Conclusion
Terlipressin is an effective vasopressor agent that could be an alternative or complementary therapy in children with refractory vasodilatory septic shock.
Supporting Evidence
- Terlipressin treatment induced a rapid and sustained improvement in mean arterial blood pressure.
- 14 out of 16 patients were able to reduce their catecholamine infusion rate after one hour of treatment.
- Seven patients survived the septic shock episode.
Takeaway
Terlipressin helps kids with very low blood pressure due to severe infections, but it can also cause problems like tissue damage.
Methodology
A prospective, multicenter, observational study was conducted in nine pediatric intensive care units in Spain over a 12-month period.
Potential Biases
The compassionate use of terlipressin may introduce bias due to the lack of a control group.
Limitations
The small number of patients and the observational nature of the study limit the generalizability of the findings.
Participant Demographics
Children aged 1 month to 13 years with severe septic shock.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website